Suppr超能文献

Apelin 在多囊卵巢综合征患者中是否为一种新的生物标志物?

Is Apelin a new biomarker in patients with polycystic ovary syndrome?

机构信息

1st Department of Internal Medicine, Medical Faculty of P. J. Šafarik University, Košice, Slovakia.

出版信息

Physiol Res. 2021 Dec 30;70(Suppl4):S635-S641. doi: 10.33549/physiolres.934708.

Abstract

Polycystic ovary syndrome (PCOS) is associated with multiple risk factors for cardiovascular diseases, including insulin resistance, diabetes mellitus type 2, obesity, hypertension, and dyslipidaemia. Many studies have assessed the role of adipokines in the etiopathogenesis of PCOS, however, no single biomarker has been recognized to be in causal relation to the syndrome. Apelin has been identified as a new adipokine linked to obesity and insulin resistance. Some studies demonstrated that the apelin / apelin receptor could play a pivotal role in the pathogenesis of polycystic ovary syndrome, however the other yielded controversial results. Underlying mechanisms of possible involvement of apelin/apelin receptor complex are discussed.

摘要

多囊卵巢综合征(PCOS)与心血管疾病的多种危险因素相关,包括胰岛素抵抗、2 型糖尿病、肥胖、高血压和血脂异常。许多研究评估了脂肪因子在 PCOS 发病机制中的作用,然而,没有单一的生物标志物被认为与该综合征有因果关系。Apelin 已被确定为一种与肥胖和胰岛素抵抗相关的新型脂肪因子。一些研究表明,apelin/apelin 受体可能在多囊卵巢综合征的发病机制中发挥关键作用,但其他研究结果则存在争议。本文讨论了 apelin/apelin 受体复合物可能参与的潜在机制。

相似文献

7
Polycystic ovary syndrome, adipose tissue and metabolic syndrome.多囊卵巢综合征、脂肪组织与代谢综合征
Arch Gynecol Obstet. 2017 Sep;296(3):405-419. doi: 10.1007/s00404-017-4429-2. Epub 2017 Jun 22.

本文引用的文献

10
New markers of insulin resistance in polycystic ovary syndrome.多囊卵巢综合征中胰岛素抵抗的新标志物
J Endocrinol Invest. 2017 Jan;40(1):1-8. doi: 10.1007/s40618-016-0523-8. Epub 2016 Jul 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验